400 related articles for article (PubMed ID: 30042077)
21. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
Schneider LS; Dagerman KS; Insel P
JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic drugs
Siafis S; Deste G; Ceraso A; Mussoni C; Vita A; Hasanagic S; Schneider-Thoma J; Papazisis G; Davis JM; Leucht S
Psychol Med; 2020 Nov; 50(15):2622-2633. PubMed ID: 31625485
[TBL] [Abstract][Full Text] [Related]
23. Lithium for schizophrenia.
Leucht S; McGrath J; Kissling W
Cochrane Database Syst Rev; 2003; (3):CD003834. PubMed ID: 12917990
[TBL] [Abstract][Full Text] [Related]
24. Zuclopenthixol dihydrochloride for schizophrenia.
Kumar A; Strech D
Cochrane Database Syst Rev; 2005 Oct; (4):CD005474. PubMed ID: 16235403
[TBL] [Abstract][Full Text] [Related]
25. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
26. Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis.
Paris G; Bighelli I; Deste G; Siafis S; Schneider-Thoma J; Zhu Y; Davis JM; Vita A; Leucht S
Schizophr Res; 2021 Mar; 229():3-11. PubMed ID: 33607608
[TBL] [Abstract][Full Text] [Related]
27. Adverse events after antipsychotic discontinuation: an individual participant data meta-analysis.
Brandt L; Schneider-Thoma J; Siafis S; Efthimiou O; Bermpohl F; Loncar L; Neumann K; Hasan A; Heinz A; Leucht S; Gutwinski S
Lancet Psychiatry; 2022 Mar; 9(3):232-242. PubMed ID: 35183280
[TBL] [Abstract][Full Text] [Related]
28. Benzodiazepines for schizophrenia.
Volz A; Khorsand V; Gillies D; Leucht S
Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
[TBL] [Abstract][Full Text] [Related]
29. Haloperidol versus placebo for schizophrenia.
Joy CB; Adams CE; Lawrie SM
Cochrane Database Syst Rev; 2001; (2):CD003082. PubMed ID: 11406070
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine for schizophrenia.
Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640
[TBL] [Abstract][Full Text] [Related]
31. Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials.
Kishi T; Matsunaga S; Iwata N
Schizophr Bull; 2016 Nov; 42(6):1438-1445. PubMed ID: 27086079
[TBL] [Abstract][Full Text] [Related]
32. Clozapine versus typical neuroleptic medication for schizophrenia.
Wahlbeck K; Cheine M; Essali MA
Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
Schneider-Thoma J; Chalkou K; Dörries C; Bighelli I; Ceraso A; Huhn M; Siafis S; Davis JM; Cipriani A; Furukawa TA; Salanti G; Leucht S
Lancet; 2022 Feb; 399(10327):824-836. PubMed ID: 35219395
[TBL] [Abstract][Full Text] [Related]
34. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
36. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
Leucht S; Leucht C; Huhn M; Chaimani A; Mavridis D; Helfer B; Samara M; Rabaioli M; Bächer S; Cipriani A; Geddes JR; Salanti G; Davis JM
Am J Psychiatry; 2017 Oct; 174(10):927-942. PubMed ID: 28541090
[TBL] [Abstract][Full Text] [Related]
37. Pimozide for schizophrenia or related psychoses.
Mothi M; Sampson S
Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
[TBL] [Abstract][Full Text] [Related]
38. Perazine for schizophrenia.
Leucht S; Hartung B
Cochrane Database Syst Rev; 2002; (1):CD002832. PubMed ID: 11869638
[TBL] [Abstract][Full Text] [Related]
39. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
40. Valproate for schizophrenia.
Schwarz C; Volz A; Li C; Leucht S
Cochrane Database Syst Rev; 2008 Jul; (3):CD004028. PubMed ID: 18646098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
